Home » Epilepsy Blog » News and Research » Benefit concert makes for a legendary Purple Day

Benefit concert makes for a legendary Purple Day

IMG_2042On March 24 the Epilepsy Foundation of New Jersey marked Purple Day with a benefit concert at the legendary Stone Pony. The event raised $12,000 which is more than double what they raised at event in 2012. There were more than 300 people in attendance including Eric Miller of Candlelight Concerts, Gary Hoey, Jann Klose as well as other amazing acts.

Purple Day concert photos

Day full of surprises

Jann Klose and Gary Hoey met at a Candlelight Concert on March 23, the night before. They hit it off so well, Gary invited Jann to join him on stage at the Stone Pony. Throughout their set they would play one of Jann’s songs, then one of Gary’s songs. While one was lead, the other would back up on vocals and guitar. The set was amazing.

Here is short clip:

The day concluded with a surprise jam session featuring Gary Hoey, Jann Klose, Brian Zaleski (Almost Easy Band) and Danny Coleman of Rock on Radio on drums!

author avatar
Jessica K. Smith Founder and CEO; Executive Director
Jessica Keenan Smith is a patient advocate and epilepsy community leader with more than 15 years of experience. As Founder and CEO of Living Well With Epilepsy and Executive Director of ASENT she bridges the gap between the scientific and patient communities, with a particular focus on the needs of the epilepsies. Jessica Keenan Smith is Founder and CEO of Living Well With Epilepsy, an award winning online resource for people affected by epilepsy to share stories and access in-depth information on the disease. Since 2009, Living Well With Epilepsy (https://livingwellwithepilepsy.com) has been featured in Forbes, Wired, NBC, NPR and the cover story of Epilepsy Advocate Magazine and has partnered with companies such as UCB, Lundbeck, Sunovion, Eisai, and more. Ms. Smith is also the Executive Director of the American Society for Experimental Neurotherapeutics (ASENT) (https://asent.org), an organization that brings together leaders from industry, academia, government and advocacy who are engaged in bringing drugs and devices to market across all neurologic disease states. In this role she is responsible for leading a successful scientific journal and annual scientific conference with speakers from all over the world.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.